Today: 9 June 2026
NuScale Power stock slips as Capitol Hill nuclear hearing puts SMR trade back in play
7 January 2026
1 min read

NuScale Power stock slips as Capitol Hill nuclear hearing puts SMR trade back in play

New York, January 7, 2026, 10:12 EST — Regular session

  • NuScale Power shares were down about 1.6% in morning trade, with volume topping 7 million shares.
  • Investors were focused on a 10:15 a.m. ET House hearing on nuclear licensing and deployment.
  • Traders are watching for policy signals now and the company’s next earnings update in early March.

NuScale Power Corp shares fell 1.6% to $19.25 on Wednesday morning, after trading between $18.51 and $19.48 in early dealings. Volume topped 7 million shares as the stock stayed jumpy.

The selling came as investors turned to a House Energy and Commerce subcommittee hearing scheduled for 10:15 a.m. ET that will look at nuclear licensing and deployment. Small modular reactors, or SMRs, are smaller plants meant to be built in factory-made modules and assembled on site.

Policy headlines have kept nuclear names on traders’ screens after the U.S. Energy Department this week awarded $2.7 billion of orders to expand domestic uranium enrichment, including for high-assay low-enriched uranium (HALEU), a fuel enriched to between 5% and 20% used in some advanced reactor designs. Energy Secretary Chris Wright said the awards show the administration is committed to rebuilding a U.S. nuclear fuel supply chain.

The broader market was edging higher, with the SPDR S&P 500 ETF up 0.1% and the Invesco QQQ up 0.2%. Nuclear-linked stocks were mixed: Oklo was up 3.7%, while Cameco and Constellation Energy were down about 0.4% and 1.4%, respectively.

NuScale is aiming to be the first U.S. developer to build an SMR, after the Nuclear Regulatory Commission approved the company’s upgraded 77-megawatt reactor design in May. That sign-off covers the blueprint, not a site permit, and NuScale still needs customer commitments and financing; it canceled its Carbon Free Power Project in 2023 after costs rose.

Wednesday’s hearing, titled “American Energy Dominance: Dawn of the New Nuclear Era,” is set to hear from Nuclear Energy Institute chief Maria Korsnick and Idaho National Laboratory director John Wagner, among others, according to Congress.gov. Traders will watch for hints of faster timelines for permits and whether lawmakers press for new federal backstops for first-of-a-kind projects. Congress.gov

But the stock remains a policy bet more than an operating story. NuScale’s last earnings update was on Nov. 6, and it is still in the early stages of turning a certified design into a financed, built plant — a process where delays and cost creep can hit hard.

Stock Market Today

  • AmpliTech Shares Surge 26.7% on 5G Open RAN Testing Update
    June 9, 2026, 9:16 AM EDT. AmpliTech (AMPG) shares surged 26.7% to $6.57 following its Open RAN testing update at the O-RAN Alliance Global PlugFest Spring 2026. The company's 64T64R Massive MIMO radio, which uses multiple antennas to enhance wireless capacity, was the only one of its kind tested with equipment from major operators including AT&T and Deutsche Telekom. Despite the strong test results, no new sales orders were announced, leaving investors cautious about future revenue impact. AmpliTech reported a 48.6% increase in first-quarter revenue to $5.35 million but remains unprofitable, narrowing its net loss to $1.52 million. The firm holds $18.4 million in cash and securities. Open RAN aims to enable multi-vendor interoperability in 5G networks, a critical push in telecom infrastructure modernization.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope
Previous Story

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop